Navigation Links
Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial

dy of DMXAA (AS1404) combined with carboplatin and paclitaxel in recurrent ovarian cancer).

Background on ASA404 ASA404 (DMXAA, formerly AS1404) is a small-molecule vascular disrupting agent which targets the blood vessels that nourish tumours. The drug was discovered by Professors Bruce Baguley and William Denny and their teams at the Auckland Cancer Society Research Centre, University of Auckland, New Zealand. It was in-licensed by Antisoma from Cancer Research Ventures Limited (now Cancer Research Technology) in August 2001. Antisoma signed a worldwide development and marketing agreement for ASA404 with Novartis in April 2007.

Background on Antisoma Based in London, UK, Antisoma is a biopharmaceutical company that develops novel products for the treatment of cancer. Antisoma fills its development pipeline by acquiring promising new product candidates from internationally recognised academic or cancer research institutions. Its core activity is the preclinical and clinical development of these drug candidates. Please visit www.antisoma.com for further information.


'"/>




Page: 1 2 3

Related medicine technology :

1. Data supporting three Antisoma programmes presented at AACR
2. Antisoma plc (UK) - Second lung cancer trial adds to positive data on AS1404
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
(Date:11/6/2009)..., Nov. 6 Derma Science...f advanced wound care products, announced plans to...ket on Monday, November 16, 2009. The Company will...he results at 11:00 am EST. Interested parties sho...84 (international), with passcode 81416481 to acce...
(Date:11/6/2009)...., Nov. 6 Philips Respironics appl...l and Prevention (CDC) to raise awareness about an...sufficiency. The CDC,s release of the first-ever g...ces in sleeplessness is a milestone in quantifying...ng-time educator, industry leader and sleep therap...
(Date:11/6/2009)... Cyberonics, Inc. (Nasda...eport financial results for the second quarter end...l 30, 2010 on Wednesday, November 18, 2009 at 5:00...ll to discuss those results on Thursday, November ...Second Quarter Results Conference Call Instruction...
Breaking Medicine Technology:Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 2Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results 2Abbott Announces New EAS 28R 29 Myoplex 28R 29 Strength Formula Nutrition Shake and Debuts Bottle Packaging 48284 1Abbott Announces New EAS 28R 29 Myoplex 28R 29 Strength Formula Nutrition Shake and Debuts Bottle Packaging 48284 2Abbott Announces New EAS 28R 29 Myoplex 28R 29 Strength Formula Nutrition Shake and Debuts Bottle Packaging 48284 3Abbott Announces New EAS 28R 29 Myoplex 28R 29 Strength Formula Nutrition Shake and Debuts Bottle Packaging 48284 4Abbott Announces New EAS 28R 29 Myoplex 28R 29 Strength Formula Nutrition Shake and Debuts Bottle Packaging 48284 5AssureRx Adds New CEO 12542 1AssureRx Adds New CEO 12542 2How Prepared are Americas Communities to Handle the Aging Boom 3F 48283 1How Prepared are Americas Communities to Handle the Aging Boom 3F 48283 2How Prepared are Americas Communities to Handle the Aging Boom 3F 48283 3How Prepared are Americas Communities to Handle the Aging Boom 3F 48283 4
...Nov. 21 Commenting on a study,of lung transplanta...pediatric pulmonologist calls the study "startling...al of Medicine that accompanies the study., Julia...ndowed Chair in,Pediatric Pulmonary Medicine at Th... study by a University of Utah research team, whic...
...of a new cytokine called IL-35 could allow clinici...mune response, MEMPHIS, Tenn., Nov. 21 Investiga... discovered a new signaling molecule,that prevents...he body. The,finding could lead to the development... autoimmune diseases, such as Type 1 diabetes; and...
Other Medicine Technology:Pediatric Pulmonary Expert Comments on Study of Lung Transplants for Cystic Fibrosis 2St. Jude Finds Molecule That Could Improve Cancer Vaccine and Therapy for Other Diseases 2
(Date:11/7/2009)... Forget ‘sweatox’ or ‘Bo...he usage of the anti-ageing jab ‘Breastox&rs... into the décolletage, can reduce the appea...rea around the breasts, leaving smoother, younger-...ovember 7, 2009 -- Transform, the UK’s large...
(Date:11/6/2009)... TSX: COM , VANCOUVER, Nov. 6 /PRNewswire-FirstCal...COM) today announced that it will report financial... 2009 on the morning of Monday, November 9, 2009. ...st at 9:00am Eastern (6:00am Pacific) on that day ...e call, please dial 416-695-7806 or 888-789-9572 a...
(Date:11/6/2009)..., N.J. and COLUMBUS, Ohio, Nov. 6 Authentidate Ho... of secure Health Information Exchange and workflo... that allows Inscrybe® Healthcare to be easil...eading information systems, Definitive Homecare So...cluded in the CPR+ Integrated Solutions Provider p...
(Date:11/6/2009)...Y., Nov. 6 The Leukemia & Lymphoma Societ...Give & Get program, which in its first two cam...than $1 million to support LLS,s blood cancer rese...vices. ,, During the campaign, taking place from N...adable 30% discount coupons participants can use...
(Date:11/6/2009)...., Nov. 6 Healthcare Trust of America, Inc. (the ...nvestment trust, announced the execution of a Purc...re a medical office building located in Englewood,...ampden Place Medical Center is located within the ...se redevelopment district. Hampden Place is locate...
Breaking Medicine News(10 mins):Health News:UK Boobs Get a Boost with 'Breastox' 2Health News:Cardiome to Release Third Quarter Results 2Health News:Cardiome to Release Third Quarter Results 3Health News:Authentidate Introduces New Interface for Inscrybe Healthcare with Definitive Homecare Solutions' CPR+ 2Health News:Authentidate Introduces New Interface for Inscrybe Healthcare with Definitive Homecare Solutions' CPR+ 3Health News:Authentidate Introduces New Interface for Inscrybe Healthcare with Definitive Homecare Solutions' CPR+ 4Health News:Get a Jump on Your Holiday Shopping and Give Two Gifts This Season: One to Your Loved Ones and One to People Battling Blood Cancer 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 66,339 SF Medical Office Building Located in Englewood, Colorado 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 66,339 SF Medical Office Building Located in Englewood, Colorado 3
...Call/ - QLT Inc. (NASDAQ: QLTI;,TSX: QLT) announce...d Phase,II study, in patients with subfoveal choro...ated macular degeneration (AMD), showed that a,com...t six months to gain similar visual acuity compare...
...s to try technology like sensors,to detect falls a...pliances, but cost, perception, and technical issu... adults want to,use technology so they can age saf...intain equipment remain barriers for,people 65-plu...
...orporation (NYSE: SYK ) announced that it will ho...t 4:30 p.m., Eastern Time, to discuss the,Company,..., 2008 and,provide an operational update. Operatin...Dean H.,Bergy, Vice President and Chief Financial ...
...ost esteemed scientists is Professor Patrick Tam f...I) who has just been elected as a Fellow of the Au... Frazer and Fiona Stanley are also among only 400 ...team have recently completed a fate map of early e...
...ke Bogda, Timothy Sawyer Promoted; ..., March 28 Barr,Pharmaceuticals, Inc. (NYSE: BRL... management team to better align the Company,s glo...tive,Officer, Bruce L. Downey, announced the follo...
...oration announces a,call for research papers invol...Lock device is designed to promote best practice f...ng contamination of the administration,set when di...acing the need for single-use, sterile caps. Baxa ...
Other Medicine News:Health News:Positive results from Visudyne(R) combination therapy study reported at Annual Macula Society Conference 2Health News:Positive results from Visudyne(R) combination therapy study reported at Annual Macula Society Conference 3Health News:Positive results from Visudyne(R) combination therapy study reported at Annual Macula Society Conference 4Health News:Older People Want to Use Technology to Help Them Remain at Home 2Health News:Older People Want to Use Technology to Help Them Remain at Home 3Health News:Older People Want to Use Technology to Help Them Remain at Home 4Health News:Stryker to Host Conference Call on April 17, 2008 2Health News:National recognition for top scientist 2Health News:Barr Announces Reorganization of Senior Management, Business Functions 2Health News:Barr Announces Reorganization of Senior Management, Business Functions 3Health News:Barr Announces Reorganization of Senior Management, Business Functions 4Health News:Barr Announces Reorganization of Senior Management, Business Functions 5Health News:Barr Announces Reorganization of Senior Management, Business Functions 6Health News:Barr Announces Reorganization of Senior Management, Business Functions 7Health News:Baxa Corporation Launches Call for Research Papers 2
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
Medicine Products: